SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001005150-02-000314
Filing Date
2002-03-19
Accepted
2002-03-19 00:00:00
Documents
2
Period of Report
2002-03-07
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8-k.txt 8-K 4245
3 EXHIBIT 99.1 ex99-1.txt EX-99.1 3838
  Complete submission text file 0001005150-02-000314.txt   9860
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15070 | Film No.: 02578894
SIC: 2834 Pharmaceutical Preparations